Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic
暂无分享,去创建一个
V. Shaygannejad | A. Maghzi | M. Ghajarzadeh | Mahdi Barzegar | O. Mirmosayyeb | Nasim Nehzat | Saeed Vaheb
暂无分享,去创建一个
V. Shaygannejad | A. Maghzi | M. Ghajarzadeh | Mahdi Barzegar | O. Mirmosayyeb | Nasim Nehzat | Saeed Vaheb